ArticleVaccines2024

A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18-64 Years in the United States.

Myron J Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.